Order Article Reprints

Amanova Z, Sametova Z, Chervyakova O, Turyskeldi S, Kurmasheva A, Abitayev R, Ussembay A, Kondibayeva Z, Toktyrova D, Mazbayeva D, et al. BelloStage™-3000 Bioreactor Versus Conventional Cultivation of Recombinant Capripoxvirus Expressing Brucella Antigens in Vero Cells: A Step Towards the Development of a New Human Brucellosis Vaccine. Cells. 2025; 14(20):1631. https://doi.org/10.3390/cells14201631

Amanova, Zhanat, Zhanna Sametova, Olga Chervyakova, Sholpan Turyskeldi, Alina Kurmasheva, Ruslan Abitayev, Abdurakhman Ussembay, Zhanat Kondibayeva, Dariya Toktyrova, Dana Mazbayeva, and et al. 2025. "BelloStage™-3000 Bioreactor Versus Conventional Cultivation of Recombinant Capripoxvirus Expressing Brucella Antigens in Vero Cells: A Step Towards the Development of a New Human Brucellosis Vaccine" Cells 14, no. 20: 1631. https://doi.org/10.3390/cells14201631

Amanova, Z., Sametova, Z., Chervyakova, O., Turyskeldi, S., Kurmasheva, A., Abitayev, R., Ussembay, A., Kondibayeva, Z., Toktyrova, D., Mazbayeva, D., & Bulatov, Y. (2025). BelloStage™-3000 Bioreactor Versus Conventional Cultivation of Recombinant Capripoxvirus Expressing Brucella Antigens in Vero Cells: A Step Towards the Development of a New Human Brucellosis Vaccine. Cells, 14(20), 1631. https://doi.org/10.3390/cells14201631